Published on
October 19, 2022
- 09:00 GMT
Alvotech and JAMP Pharma Expand Exclusive Partnership Adding Two Biosimilar Candidates for Canadian Market, Bringing New Options ...
Expanded partnership covers biosimilar candidates in immunology and oncology REYKJAVIK, Iceland and BOUCHERVILLE, Quebec, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of …
Distribution channels:
Companies, Technology
...
